-
Jun 26, 2015, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA, US - Jun 26, 2015 - Biogen Idec
Inc. - Product Pipeline Review -
2014SummaryGlobal Markets Direct's,
'Biogen Idec Inc
Full story
-
Jun 25, 2015, 15:00 PM
by
Michael Croft
Bio-IT World | The Icahn School of Medicine at Mount Sinai today announced the Harris Center for Precision Wellness. The center is part of the Icahn Institute for Genomics and Multiscale Biology and will be directed by Joel Dudley of the Icahn Institute and Gregory Stock, formerly of UCLA.
Full story
-
Jun 25, 2015, 00:00 AM
by
Michael Croft
EDINBURGH, UNITED KINGDOM - Jun 25, 2015 - Aridhia
partners with NHS, University of Glasgow and Philips
Healthcare on unique brain injury study Aridhia
Informatics today announced a two-year funded collaboration
with NHS Greater Glasgow and Clyde, the University of
Glasgow and Philips Healthcare
Full story
-
Jun 25, 2015, 00:00 AM
by
Michael Croft
SAN FRANCISCO, CA, US - Jun 25, 2015 - Istituto
Italiano di Tecnologia - Product Pipeline Review -
2014SummaryGlobal Markets Direct's,
'Istituto Italiano di Tecnologia - Product Pipeline Review - 2014',
provides an overview of the Istituto Italiano di Tecnologia's
pharmaceutical research and development focus
Full story
-
Jun 24, 2015, 09:00 AM
by
Michael Croft
Bio-IT World News Brief | This morning Google Genomics announced a partnership with the Broad Institute of MIT and Harvard to, “combine the power, security, and scale of Google Cloud Platform with Broad Institute’s expertise in scientific analysis.” The first offering will be the GATK on Google Cloud Platform.
Full story
-
Jun 23, 2015, 00:00 AM
by
Michael Croft
In the Pipeline | Here's a disturbing read for
you: the author of this paper (Morten Oksvold, of Oslo University)
sat down and did what none of us ever do. He chose three different
journals in the oncology field, picked one hundred and twenty
papers, at random, from their recent issues, and carefully looked
every one of them over for duplications in the figures and data. On
PubPeer, you can see what he found. Nearly a quarter of the papers
had problems.
Full story
-
Jun 22, 2015, 13:20 PM
by
Michael Croft
Diagnostics World | Color Genomics is just one of several companies toying with a new model for selling low-priced DNA tests online, by enlisting physicians as intermediaries. If Color's business model becomes popular, it will have
big implications for the way genomic testing reaches the broader public — and who sets the standards for this maturing technology.
Full story
-
Jun 19, 2015, 09:00 AM
by
Michael Croft
Clinical Informatics News | The cost-to-value equation for standardizing clinical data is broken. Pharmaceutical companies spend millions of dollars annually, and substantially delay products’ time to market, sending clinical data to contractors for preparation and integration before analysis. Why is the standardization process for clinical data still manual?
Full story
-
Jun 18, 2015, 08:35 AM
by
Michael Croft
Bio-IT World | Emulate, a for-profit spinoff of Harvard's Wyss Institute, is announcing that a partnership with Johnson & Johnson has produced a new Thrombosis-on-Chip model for testing drug candidates and studying the biology of blood clotting, in a preview of the company's model for creating and disseminating next-generation organs-on-chips.
Full story
-
Jun 18, 2015, 00:00 AM
by
Michael Croft
Computerworld | Google has been building its own
software-defined data-center networks for 10 years because
traditional gear can't handle the scale of its warehouse-sized
computers.
Full story
-
Jun 18, 2015, 00:00 AM
by
Michael Croft
MIT Technology Review | Supercharge your immune
cells to defeat cancer? Juno Therapeutics believes its treatments
can do exactly that.
Full story
-
Jun 18, 2015, 00:00 AM
by
Michael Croft
SHIRLEY, NY - Jun 18, 2015 - Tags: bioanalysis, biological analysis, mass spectrometry From Janssen company:Biomarker is a part of all phases of drug development
Full story
-
Jun 17, 2015, 00:00 AM
by
Michael Croft
EDINBURGH, UNITED KINGDOM - Jun 17, 2015 - ARIDHIA'S
DATA SCIENCE PLATFORM USED IN SIX MILLION EURO EU
PROJECT Aridhia's data science
platform AnalytiXagility has been chosen to underpin a €6
million oral healthcare innovation project funded by the
EU's Horizon 2020 programme and the
funding win demonstrates huge confidence in Aridhia's
data analytics capability
Full story
-
Jun 17, 2015, 00:00 AM
by
Michael Croft
ALBUQUERQUE, NM, UNITED STATES - Jun 17, 2015 - Genedata and IntelliCyt today announced an alliance that brings together the market-leading strengths of each company to transform screening of suspension cells
Full story
-
Jun 16, 2015, 15:00 PM
by
Michael Croft
Bio-IT World News Brief | Tute Genomics today announced the closing of its Series A1 round of venture capital funding. The company raised over $3.9 million from a strategic group of investors, including Intermountain Healthcare, Healthbox, and China-based Tencent.
Full story
-
Jun 16, 2015, 08:50 AM
by
Michael Croft
Bio-IT World News Brief | Nature Methods has published a paper by researchers at the University of Birmingham and University of Toronto, demonstrating a complete de novo assembly of an E. coli genome using only data from an Oxford Nanopore MinION Sequencer.
Full story
-
Jun 16, 2015, 00:00 AM
by
Michael Croft
Xconomy | Trunnell leaves the Broad to serve as
the chief information officer as the biomedical institution moves
into an era of deep genomic sequencing.
Full story
-
Jun 16, 2015, 00:00 AM
by
Michael Croft
mobihealthnews | PatientsLikeMe has announced a
research partnership with the FDA: The agency will assess the
platform's feasibility as a way to generate adverse event reports,
which the FDA uses to regulate drugs after their release into the
market.
Full story
-
Jun 11, 2015, 00:00 AM
by
Michael Croft
SAN DIEGO, CA, UNITED STATES - Jun 11, 2015 - Agena Bioscience today expanded its European distributors through new relationships with KAWA.SKA in Poland and BioGen-Analytica in Russia
Full story
-
Jun 10, 2015, 13:30 PM
by
Michael Croft
Bio-IT World News Brief | A supplementary document to a recent Nature Biotechnology article on the use of CRISPR-Cas9 genome editing in the human germline offers complete Q&A's with over 20 experts in the field, taking on pressing questions about how and whether this technology can be regulated.
Full story